NEW YORK (GenomeWeb) – RNAi research firm Advirna this month secured a six-month, $150,000 grant from the National Science Foundation to develop a novel line of tools based on the gene-silencing technology.

According to the company, which currently markets a line of siRNAs that do not require transfection reagents or delivery vehicles for research applications, the use of existing RNAi technologies for the study of genes in mammalian cells continues to be hampered by off-target effects and high costs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.